DE2829975A1 - Antitumor wirksame substanz, deren herstellung und verwendung - Google Patents

Antitumor wirksame substanz, deren herstellung und verwendung

Info

Publication number
DE2829975A1
DE2829975A1 DE19782829975 DE2829975A DE2829975A1 DE 2829975 A1 DE2829975 A1 DE 2829975A1 DE 19782829975 DE19782829975 DE 19782829975 DE 2829975 A DE2829975 A DE 2829975A DE 2829975 A1 DE2829975 A1 DE 2829975A1
Authority
DE
Germany
Prior art keywords
substance
microorganism
culture broth
tumor
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782829975
Other languages
German (de)
English (en)
Inventor
Takao Kiyohara
Shigeo Ogino
Noboru Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2829975A1 publication Critical patent/DE2829975A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE19782829975 1977-07-11 1978-07-07 Antitumor wirksame substanz, deren herstellung und verwendung Withdrawn DE2829975A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52083129A JPS58318B2 (ja) 1977-07-11 1977-07-11 制癌性物質の製造方法

Publications (1)

Publication Number Publication Date
DE2829975A1 true DE2829975A1 (de) 1979-01-25

Family

ID=13793578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782829975 Withdrawn DE2829975A1 (de) 1977-07-11 1978-07-07 Antitumor wirksame substanz, deren herstellung und verwendung

Country Status (9)

Country Link
US (1) US4209507A (cg-RX-API-DMAC7.html)
JP (1) JPS58318B2 (cg-RX-API-DMAC7.html)
CA (1) CA1119540A (cg-RX-API-DMAC7.html)
CH (1) CH639133A5 (cg-RX-API-DMAC7.html)
DE (1) DE2829975A1 (cg-RX-API-DMAC7.html)
FR (1) FR2397193B1 (cg-RX-API-DMAC7.html)
GB (1) GB2000680B (cg-RX-API-DMAC7.html)
IT (1) IT1099569B (cg-RX-API-DMAC7.html)
SE (1) SE7807645L (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151639B (da) * 1979-08-24 1987-12-21 Toyama Chemical Co Ltd Fremgangsmaade til fremstilling af tf-100 eller fraktioner heraf med carcinostatisk og immunostimulerende aktivitet

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5635989A (en) * 1979-08-16 1981-04-08 Sumitomo Chem Co Ltd Preparation of carcinostatic substance
EP0157544A3 (en) * 1984-03-29 1987-08-05 Takeda Chemical Industries, Ltd. Antibiotics, their production and use
US4751182A (en) * 1984-04-20 1988-06-14 Wisconsin Alumni Research Foundation Process for preparing L-carnitine from DL-carnitine
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
JPH0259056A (ja) * 1988-08-25 1990-02-28 Midori Anzen Kk 空気清浄機
CH677325A5 (cg-RX-API-DMAC7.html) * 1989-04-28 1991-05-15 Asea Brown Boveri

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151639B (da) * 1979-08-24 1987-12-21 Toyama Chemical Co Ltd Fremgangsmaade til fremstilling af tf-100 eller fraktioner heraf med carcinostatisk og immunostimulerende aktivitet

Also Published As

Publication number Publication date
JPS58318B2 (ja) 1983-01-06
FR2397193A1 (cg-RX-API-DMAC7.html) 1979-02-09
CA1119540A (en) 1982-03-09
FR2397193B1 (cg-RX-API-DMAC7.html) 1981-07-24
SE7807645L (sv) 1979-01-12
IT7825570A0 (it) 1978-07-11
US4209507A (en) 1980-06-24
GB2000680A (en) 1979-01-17
CH639133A5 (de) 1983-10-31
GB2000680B (en) 1982-04-07
IT1099569B (it) 1985-09-18
JPS5420196A (en) 1979-02-15

Similar Documents

Publication Publication Date Title
DE3017372A1 (de) Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung
DE3134353C2 (de) Antibiotikum BMG162-aF2, Verfahren zu seiner Herstellung und dieses enthaltende Antitumormittel
DE69116601T2 (de) Verfahren zur Herstellung von Antitumordextran
DD215580A5 (de) Hypocholesterolaemisch aktives protein
DE2829975A1 (de) Antitumor wirksame substanz, deren herstellung und verwendung
DE2926406A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
DE69026371T2 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
CH657989A5 (de) Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
DE69107815T2 (de) Verfahren zur Herstellung neuer nichtkovalenten Polysaccharid-Protein-Zusammensetzungen mit pharmakologischen Eigenschaften.
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
DE3012014A1 (de) Istamycine und verfahren zur herstellung derselben
DE3329255C2 (de) Verfahren zur Herstellung der Substanz TF-500 mit carcinostatischen und immunostimulierenden Eigenschaften
DE2146674C3 (de) Faktor und seine Verwendung als Arzneimittel
DE2803681C2 (cg-RX-API-DMAC7.html)
DE2532589A1 (de) Polypeptid und verfahren zur herstellung desselben und mittel mit einem gehalt desselben
DE3015030C2 (cg-RX-API-DMAC7.html)
DE2737943A1 (de) Neue antibiotika, substanzen sf-1130- x tief 1 und -x tief 2 , verfahren zu ihrer herstellung und ihre verwendung
DD295764A5 (de) Herstellungsverfahren fuer ein extrazellulaeres exopolymer, das auf diese weise erhaltene exopolymer und pharmazeutische zubereitungen, in denen es enthalten ist.
DE3031152C2 (cg-RX-API-DMAC7.html)
DE945470C (de) Herstellung von Streptogramin
EP0024206A2 (en) Antitumor substance, composition comprising it and process for preparing said substance
DE1617868A1 (de) Verfahren zur Herstellung einer anticanceroes wirksamen Substanz
DE2639410A1 (de) Biologisch aktive substanz und verfahren zu ihrer herstellung
DE2921829A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination